THOMAS L. HARRISON - 17 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/ Christine M. Klaskin, as Attorney-in-Fact for Thomas Harrison
Issuer symbol
AGEN
Transactions as of
17 Jun 2025
Net transactions value
+$25,622
Form type
4
Filing time
15 Jul 2025, 16:05:04 UTC
Previous filing
03 Apr 2025
Next filing
03 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HARRISON THOMAS L Director C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON /s/ Christine M. Klaskin, as Attorney-in-Fact for Thomas Harrison 14 Jul 2025 0001247340

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $25,622 +7,401 +83% $3.46 16,299 01 Jul 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +17,500 +140% $0.000000 30,000 17 Jun 2025 Common Stock 17,500 $3.02 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive their director fees in shares of Ageuns' common stock.
F2 $3.462 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.
F3 Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.